One of the most remarkable aspects of last week’s U.S. Senate Commerce, Science & Transportation Committee hearing, (ICYMI: “Bringing Transparency and Accountability to Pharmacy Benefit Managers,”) was the number of committee members on both sides of the aisle who demonstrated a keen understanding of the PBM business model — and…

January’s come and gone while here at PUTT we’ve been actively developing PBM education programs and meeting with industry leaders and influencers over the last 4 weeks. …

Happy Holidays! Is it 2023 yet? Kidding! 2022 was such a good year for PBM reform, we’ll be a bit sad to say goodbye. We spent much of this year focused on PBM reform education, with PUTT Executive Director Monique Whitney participating on panels at the annual Community Oncology Alliance…

Next Wednesday, November 30th, a hearing will take place on a lawsuit you’ve likely never heard of, but which may have lasting implications for independent pharmacies in PBM reform battleground states. …

To Congress, the Department of Defense, and Federal Government Contract Decision Makers: Today marks the first day 15,000 community pharmacies across the U.S. can no longer serve active duty and retired military covered by TRICARE. It’s a drastic cut orchestrated by Cigna-owned Express Scripts in the name of “cost savings”…

“You should expect a choice of health care providers that is sufficient to ensure access to appropriate high-quality health care.” — TRICARE Beneficiary Brochure An apt description of how most of us already feel, “Lost Care and Broken Promises” is actually how Military.com first labeled the travesty of TRICARE decisions…

This month the Department of Justice (DOJ) meets UnitedHealth Group in court in an attempt to block the latter’s planned acquisition of Change Healthcare, not so much a healthcare company as a healthcare software company, whose value lies in its claims transmission and payment information services. …

Dear PCMA, We need to talk. It’s not good news. First, we feel we should thank you. Remarkably, your clients have somehow united the U.S. in a way usually reserved for terrorist attacks and tragic natural disasters. Also, we’re impressed at your latest PR offensive. How fascinating to watch the…

Last month, Janssen Pharmaceuticals released its 5th annual U.S. Transparency Report with a notable new addition: a detailed synopsis of how rebates, now hard-wired into insurance benefit design, essentially derail patients from accessing affordable medication. These access to care issues occur even as an elite group of Fortune 15 insurers…